Cocrystal Pharma (COCP) Accumulated Expenses (2011 - 2026)
Cocrystal Pharma (COCP) reported Accumulated Expenses of $101000.0 for Q1 2026, up 1.0% on a YoY basis from $100000.0 in Q1 2025, and up 18.82% sequentially from $85000.0 in Q4 2025.
Cocrystal Pharma (COCP) Accumulated Expenses (2011 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 15 years of Accumulated Expenses data on file, last reported at $101000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 1.0% year-over-year to $101000.0; the trailing twelve-month figure through Mar 2026 stood at $101000.0 (up 1.0% YoY), and the FY2025 full-year result was $85000.0, down 27.35% from the prior year.
- Accumulated Expenses rose to $101000.0 in Q1 2026, from $85000.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $185000.0 in Q3 2024 to a low of $85000.0 in Q4 2025.
- A 5-year average of $132294.1 and a median of $131000.0 in 2022 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses climbed 25.0% in 2022 and plunged 32.05% in 2025, its largest moves.
- Tracing COCP's Accumulated Expenses over 5 years: stood at $130000.0 in 2022, then dropped by 16.15% to $109000.0 in 2023, then advanced by 7.34% to $117000.0 in 2024, then decreased by 27.35% to $85000.0 in 2025, then grew by 18.82% to $101000.0 in 2026.
- Business Quant data shows COCP's Accumulated Expenses at $101000.0 in Q1 2026, $85000.0 in Q4 2025, and $127000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101,000.00 |
| Dec 31, 2025 | 85,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 117,000.00 |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 109,000.00 |
| Sep 30, 2023 | 173,000.00 |
| Jun 30, 2023 | 150,000.00 |
| Mar 31, 2023 | 131,000.00 |
| Dec 31, 2022 | 130,000.00 |
| Sep 30, 2022 | 165,000.00 |
| Jun 30, 2022 | 144,000.00 |
| Mar 31, 2022 | 131,000.00 |
| Dec 31, 2021 | 104,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 134,000.00 |